COMMUNIQUÉS West-GlobeNewswire

AC Immune and Lilly Announce License and Collaboration Agreement
12/12/2018
Multi-year agreement focuses on Morphomer tau aggregation inhibitors, for the potential treatment of Alzheimer's disease and other neurodegenerative diseases. AC Immune to receive an initial upfront payment of CHF80 [...]
TRU NIAGEN® to be Featured at the American Academy of Anti-Aging Medicine Annual Meeting
12/12/2018
Dr. Charles Brenner to deliver scientific presentation and “Father of Biohacking” Dave Asprey to sign copies of his new book, Game Changers LOS ANGELES, Dec. 12, 2018 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC) [...]
MediciNova to Present at the J.P. Morgan Healthcare Conference in San Francisco
12/12/2018
LA JOLLA, Calif., Dec. 12, 2018 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), [...]
Rule 2.9 Announcement
12/12/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 12 December 2018 [...]
DBV Technologies Highlights Data Supporting Induction of Immunotolerance Through the Skin at Inflammatory Skin Disease Summit 2018
12/12/2018
Montrouge, France, December 12, 2018 DBV Technologies Highlights Data Supporting Induction of Immunotolerance Through the Skin at Inflammatory Skin Disease Summit 2018 First-of-its-kind study evaluated immune profile of [...]
DBV Technologies communique des données à l'appui de l'induction de l'immunotolérance par la peau au Inflammatory Skin Disease Summit 2018
12/12/2018
Montrouge, France, le 12 décembre (07h30 CET), 2018 DBV Technologies communique des données à l'appui de l'induction de l'immunotolérance par la peau au Inflammatory Skin Disease Summit 2018 Une étude unique en son [...]
Santhera Announces Financial Results for the First Nine Months of 2018
12/12/2018
Pratteln, Switzerland, December 12, 2018 - Santhera Pharmaceuticals (SIX: SANN) reports financial results for the nine months ended September 30, 2018, and confirms its guidance and positive outlook. Santhera is on [...]
Santhera Launches Placement of Shares through Accelerated Bookbuilding
12/12/2018
Pratteln, Switzerland, December 12, 2018 - Santhera Pharmaceuticals Holding Ltd (SIX: SANN) announces the launch of an ordinary capital increase of up to 5,000,000 registered shares with a nominal value of CHF 1 each to [...]
Fluidigm Announces Pricing of Public Offering of 8,150,000 Shares of Common Stock
12/12/2018
SOUTH SAN FRANCISCO, Calif., Dec. 11, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ: FLDM), a leader in mass cytometry and microfluidics technologies, today announced the pricing of an underwritten public [...]
DiaMedica Closes Public Offering in the United States
11/12/2018
MINNEAPOLIS, Dec. 11, 2018 (GLOBE NEWSWIRE) -- DiaMedica Therapeutics Inc. (“ DiaMedica ” or the “ Company ”) (NASDAQ:DMAC; TSXV:DMA), a clinical stage biopharmaceutical company, announced today that it has completed an [...]
Intra-Cellular Therapies Announces Favorable Results From Long-Term Open-Label Safety Switching Study With Lumateperone in Patients with Schizophrenia at the 57th Annual Meeting of the American College of Neuropsychopharmacology
11/12/2018
Favorable safety results following administration of lumateperone for up to one year treatment duration are consistent with and extend the safety and tolerability profile previously reported in short-term trials Intra- [...]
Dermira Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
11/12/2018
MENLO PARK, Calif., Dec. 11, 2018 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ: DERM), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new therapies [...]
Healthcare Special Opportunities Fund Announces December 2018 Quarterly Distribution
11/12/2018
NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, Dec. 11, 2018 (GLOBE NEWSWIRE) -- (TSX:MDS.UN) – LDIC Inc. (the “Manager”), the manager of Healthcare Special Opportunities [...]
Quotient Limited Announces Receipt of the ISO 13485:2016 Certification of its State of the Art MosaiQ™ Microarray Manufacturing Facility
11/12/2018
JERSEY, Channel Islands, Dec. 11, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), today reported receipt of the formal ISO 13485:2016 certification for its [...]
Management Cease Trade Order Update
11/12/2018
HALIFAX, Nova Scotia, Dec. 11, 2018 (GLOBE NEWSWIRE) -- MedMira Inc. (TSXV: MIR) (“MedMira” or the “Company”) provides an update with respect to the previously announced management cease trade order (the “MCTO”) issued [...]
Help Your Diabetes® Added To Franchise Dictionary’s Top 100 Game Changers As “One To Watch”
11/12/2018
GRAPEVINE, Texas, Dec. 11, 2018 (GLOBE NEWSWIRE) -- Today, Help Your Diabetes®, a company that helps Type 2 Diabetics live diabetes-free lives through natural methods, announced that they have been voted into the Top [...]
NeoGenomics Announces Secondary Offering of Common Stock by Selling Stockholder
11/12/2018
FORT MYERS, Fla., Dec. 11, 2018 (GLOBE NEWSWIRE) -- NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services, today announced that GE Medical Systems Information Technologies, Inc [...]
Aeglea BioTherapeutics Announces Design of Pivotal Phase 3 PEACE Trial Evaluating Pegzilarginase in Arginase 1 Deficiency
11/12/2018
Single, Global Pivotal Trial to Support Registration; Primary Endpoint of Arginine Reduction Expected to Initiate in Q2 2019; Topline Data Anticipated in Q1 2021 Company to Host Conference Call Today at 5:00 p.m. ET [...]
Viveve Announces Closing of Public Offering of Shares of Common Stock
11/12/2018
ENGLEWOOD, Colo., Dec. 11, 2018 (GLOBE NEWSWIRE) -- Viveve Medical, Inc. (“Viveve”) (NASDAQ: VIVE), a medical technology company focused on women’s intimate health, today announced the closing of its previously [...]

Pages